IN201911052572A - - Google Patents

Download PDF

Info

Publication number
IN201911052572A
IN201911052572A IN201911052572A IN201911052572A IN201911052572A IN 201911052572 A IN201911052572 A IN 201911052572A IN 201911052572 A IN201911052572 A IN 201911052572A IN 201911052572 A IN201911052572 A IN 201911052572A IN 201911052572 A IN201911052572 A IN 201911052572A
Authority
IN
India
Application number
IN201911052572A
Inventor
Vivek Chaturvedi
Dnyaneshwar Eknath Shelke
Bhuwan BHASHKAR
Amit Bansal
Anil Kumar
Original Assignee
Mankind Pharma Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mankind Pharma Ltd. filed Critical Mankind Pharma Ltd.
Priority to IN201911052572A priority Critical patent/IN201911052572A/en
Publication of IN201911052572A publication Critical patent/IN201911052572A/en

Links

IN201911052572A 2019-12-18 2019-12-18 IN201911052572A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN201911052572A IN201911052572A (en) 2019-12-18 2019-12-18

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN201911052572A IN201911052572A (en) 2019-12-18 2019-12-18

Publications (1)

Publication Number Publication Date
IN201911052572A true IN201911052572A (en) 2021-09-03

Family

ID=82116852

Family Applications (1)

Application Number Title Priority Date Filing Date
IN201911052572A IN201911052572A (en) 2019-12-18 2019-12-18

Country Status (1)

Country Link
IN (1) IN201911052572A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022122014A1 (en) * 2020-12-11 2022-06-16 苏州科睿思制药有限公司 Crystal form of lanifibranor, preparation method therefor, and use thereof
WO2022258060A1 (en) * 2021-06-11 2022-12-15 上海启晟合研医药科技有限公司 Crystal form of lanifibranor and preparation method therefor

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022122014A1 (en) * 2020-12-11 2022-06-16 苏州科睿思制药有限公司 Crystal form of lanifibranor, preparation method therefor, and use thereof
US11827630B2 (en) 2020-12-11 2023-11-28 Crystal Pharmaceutical (Suzhou) Co., Ltd. Crystal form of lanifibranor, preparation method therefor, and use thereof
WO2022258060A1 (en) * 2021-06-11 2022-12-15 上海启晟合研医药科技有限公司 Crystal form of lanifibranor and preparation method therefor

Similar Documents

Publication Publication Date Title
BR112019017762A2 (en)
BR112021017339A2 (en)
BR112021013854A2 (en)
BR112021018450A2 (en)
BR112021017939A2 (en)
BR112021017892A2 (en)
BR112019016141A2 (en)
BR112021017738A2 (en)
BR112021017782A2 (en)
BR112019016142A2 (en)
BR112019016138A2 (en)
BR112021018168A2 (en)
BR112021017728A2 (en)
AU2020104490A5 (en)
BR112021008711A2 (en)
BR112021018452A2 (en)
BR112021017234A2 (en)
BR112021017355A2 (en)
BR112021017703A2 (en)
BR112021018102A2 (en)
BR112021017173A2 (en)
BR112021018584A2 (en)
BR112021017083A2 (en)
BR112021017637A2 (en)
BR112021015080A2 (en)